Detection of the slight elevations of CRP associated with an increased risk of cardiovascular disease, ≥ 2 mg/L, requires a “high-sensitivity” CRP assay, not the routine assay used to assess inflammation in other diseases. The gene discussed is CRP; the disease is cardiovascular disorder.